ArticleJournal of cardiovascular translational research2022

Sacubitril/Valsartan Decreases Atrial Fibrillation Susceptibility by Inhibiting Angiotensin II-Induced Atrial Fibrosis Through p-Smad2/3, p-JNK, and p-p38 Signaling Pathways.

Song-Nan Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.